Philippines HealthTech Market Overview:
According to SPER Market Research, the Philippines HealthTech Market is estimated to reach USD 0.07 billion by 2032 with a CAGR of 29.46%.
Philippines Health Tech Market had a slow growth originally. The slow growth corresponded to poor internet penetration and lack of technology mindfulness. Unorganized health tech structure and a less tech- smart population led to the accumulation of non-harmonized healthcare data. The government faced a major difficulty when the healthcare challenges kept on adding with the growing population. Adding need and high government interest appreciatively drove the Philippines health tech assiduity.
Impact of COVID-19 on the Philippines HealthTech Market
Lockdown has been a major growth motorist of the Philippines Health Tech market. Covid- 19 brought a moment of consummation for the health tech market, as it has stressed all the being gaps in the healthcare assiduity. There has been a significant increase in the end- druggies for nearly all the sectors of the health tech assiduity that ultimately redounded in the increase in the number of players in the request.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Service Type, By Basis of Competition |
| Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Companies Covered | AIDE, Ascendant Technologies, BizBox, Comologik, Dima, Exist Healthcare, eZConsult, GetMeds, HealthNow, Hybrain, KCCI Medsys, Kitika, Konsulta MD, MedCheck, Medcurial, Medifi, Medgate, MedGrocer, MedProjects, Mercury Pharmacy, My Pocket Doctor, Muramed, Rose Pharmacy, Segworks, Serious MD, South Star Drug, Watson, Zennya.
|
Philippines HealthTech Market Segmentation:
By Service Type: Based on the Service Type, Philippines Health Tech Market is segmented as; Online Consultation, E-Pharmacy, Healthcare IT Solutions.
By Basis of Competition: Based on the Basis of Competition, Philippines Health Tech Market is segmented as; Product Offered, Availability of Doctors, End Users, Partnerships.
By Region: Some regions of Philippines such as Manila, Central Luzon, Mindanao/Davao, owns the prime share of this market as during the initial months of Lockdown helped both E-Pharmacy and Online Consultation market to flourish in these regions.
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. Impacts of COVID-19 in the Philippines Health Tech Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Philippines Health Tech Market, By Service Type, 2019-2032 (USD Million)
6.1. Online Consultation
6.2. E-Pharmacy
6.3. Healthcare IT Solutions
7. Philippines Health Tech Market, By Basis of Competition, 2019-2032 (USD Million)
7.1. Product Offered
7.2. Availability of Doctors
7.3. End Users
7.4. Partnerships
8. Philippines Health Tech Market, By Region, 2019-2032 (USD Million)
8.1 Manila
8.2 Central Luzon
8.3 Mindanao/ Davao
9. Company Profiles
9.1 AIDE9.1.1 Company details
9.1.2 Financial outlook
9.1.3 Product summary
9.1.4 Recent developments
9.2 Ascendant Technologies
9.2.1 Company details
9.2.2 Financial outlook
9.2.3 Product summary
9.2.4 Recent developments
9.3 BizBox
9.3.1 Company details
9.3.2 Financial outlook
9.3.3 Product summary
9.3.4 Recent developments
9.4 Comologik
9.4.1 Company details
9.4.2 Financial outlook
9.4.3 Product summary
9.4.4 Recent developments
9.5 Dima
9.5.1 Company details
9.5.2 Financial outlook
9.5.3 Product summary
9.5.4 Recent developments
9.6 Exist Healthcare
9.6.1 Company details
9.6.2 Financial outlook
9.6.3 Product summary
9.6.4 Recent developments
9.7 eZConsult
9.7.1 Company details
9.7.2 Financial outlook
9.7.3 Product summary
9.7.4 Recent developments
9.8 GetMeds
9.8.1 Company details
9.8.2 Financial outlook
9.8.3 Product summary
9.8.4 Recent developments
9.9 HealthNow
9.9.1 Company details
9.9.2 Financial outlook
9.9.3 Product summary
9.9.4 Recent developments
9.10 Hybrain
9.10.1 Company details
9.10.2 Financial outlook
9.10.3 Product summary
9.10.4 Recent developments
9.11 KCCI Medsys
9.11.1 Company details
9.11.2 Financial outlook
9.11.3 Product summary
9.11.4 Recent developments
9.12 Kitika
9.12.1 Company details
9.12.2 Financial outlook
9.12.3 Product summary
9.12.4 Recent developments
9.13 Konsulta MD
9.13.1 Company details
9.13.2 Financial outlook
9.13.3 Product summary
9.13.4 Recent developments
9.14 MedCheck
9.14.1 Company details
9.14.2 Financial outlook
9.14.3 Product summary
9.14.4 Recent developments
9.15 Medcurial
9.15.1 Company details
9.15.2 Financial outlook
9.15.3 Product summary
9.15.4 Recent developments
9.16 Medifi
9.16.1 Company details
9.16.2 Financial outlook
9.16.3 Product summary
9.16.4 Recent developments
9.17 Medgate
9.17.1 Company details
9.17.2 Financial outlook
9.17.3 Product summary
9.17.4 Recent developments
9.18 MedGrocer
9.18.1 Company details
9.18.2 Financial outlook
9.18.3 Product summary
9.18.4 Recent developments
9.19 MedProjects
9.19.1 Company details
9.19.2 Financial outlook
9.19.3 Product summary
9.19.4 Recent developments
9.20 Mercury Pharmacy
9.20.1 Company details
9.20.2 Financial outlook
9.20.3 Product summary
9.20.4 Recent developments
9.21 My Pocket Doctor
9.21.1 Company details
9.21.2 Financial outlook
9.21.3 Product summary
9.21.4 Recent developments
9.22 Muramed
9.22.1 Company details
9.22.2 Financial outlook
9.22.3 Product summary
9.22.4 Recent developments
9.23 Rose Pharmacy
9.23.1 Company details
9.23.2 Financial outlook
9.23.3 Product summary
9.23.4 Recent developments
9.24 Segworks
9.24.1 Company details
9.24.2 Financial outlook
9.24.3 Product summary
9.24.4 Recent developments
9.25 Serious MD
9.25.1 Company details
9.25.2 Financial outlook
9.25.3 Product summary
9.25.4 Recent developments
9.26 South Star Drug
9.26.1 Company details
9.26.2 Financial outlook
9.26.3 Product summary
9.26.4 Recent developments
9.27 Watson
9.27.1 Company details
9.27.2 Financial outlook
9.27.3 Product summary
9.27.4 Recent developments
9.28 Zennya
9.28.1 Company details
9.28.2 Financial outlook
9.28.3 Product summary
9.28.4 Recent developments
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
